Exactech’s business segments increased across the board in the second quarter, with the exception of its biologic and spine business, which decreased 1 percent to $5.9 million. The company’s revenue from knee implants increased 1 percent to $21 million; extremity implants increased 24 percent to $12 million; and hip implant increased 22 percent to $10.3 million.
More Articles on Orthopedic Devices:
Study to Compare Benvenue Medical, Medtronic Spinal Systems
National Capital Region Medical Adopts HemaClear Device
Medtronic Receives 510(k) Approval for Orthopedic Sealer
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.